Dialysis world news


Dynavax Announces Receipt of Communication from the U.S. FDA on HEPLISAVTM Hepatitis B Vaccine (Centre Daily Times) PDF Print

Dynavax Technologies Corporation (Nasdaq: DVAX) today announced receipt of communication from the U.S. Food and Drug Administration (FDA) regarding the clinical hold on the two HEPLISAV TM Investigational New Drug (IND) Applications, for healthy adults and patients with end-stage renal disease (ESRD). In this communication, the FDA has requested additional clinical and safety information which ...

read more

 
FDA Asks for More Data on Dynavax Technologies Corporation (DVAX ... - Lifescience-online PDF Print

... two INDs and may assist in finding a development path forward for HEPLISAV hepatitis B vaccine, not only in ESRD patients but also in healthy adults. ...

read more

 
Brave Newport teen is in transplant queue for her life - South Wales Argus PDF Print

She has been on dialysis since May 2007 and currently has to travel to the University of Wales Hospital in Cardiff to undergo three hours of dialysis three ...

read more

 
Le Pr Hassouna Ben Ayed - Leaders Tunisie PDF Print

En 1963, il réalise la première dialyse péritonéale pour traiter des cas d’insuffisance rénale aiguë. En 1968, il est à l’origine de l’introduction du ...

read more

 
Neueinführung von CAPHOSOL(R) zur Prophylaxe und Therapie der ... - APA OTS (Pressemitteilung) PDF Print

Bone Marrow Transplant 2003;31(8):705-12.]. Über EUSA Pharma EUSA Pharma ist ein schnell wachsendes transatlantisches pharmazeutisches ...

read more

 
<< Start < Prev 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 Next > End >>

Page 2169 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.